Related Experiment Video
Updated: May 25, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Survivin gene polymorphism association with papillary thyroid carcinoma
Nasrin Yazdani1, Forough A Sayahpour, Vahid Haghpanah
1Otolaryngology and Head & Neck Surgery Research Centre, Tehran University of Medical Sciences, Iran.
The survivin gene polymorphism rs 9904341 (G/C) is linked to an increased risk of papillary thyroid carcinoma (PTC). The C allele correlates with more aggressive PTC, including lymph node and vascular involvement.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Survivin protein inhibits apoptosis and is implicated in human solid tumors.
- A common polymorphism in the survivin gene promoter at position -31 (G/C, rs 9904341) has been investigated for its association with various cancer risks.
- Understanding genetic predispositions is crucial for cancer risk assessment and management.
Purpose of the Study:
- To investigate the association between the survivin gene -31 (G/C) polymorphism (rs 9904341) and the risk of papillary thyroid carcinoma (PTC) in an Iranian population.
- To determine if this polymorphism correlates with clinical manifestations and aggressiveness of PTC.
Main Methods:
- A case-control study was conducted with 123 PTC patients and 131 healthy controls from Iran.
- Genotyping for the survivin -31 (G/C) polymorphism was performed.
- Statistical analysis, including odds ratios (OR) and confidence intervals (CI), was used to assess the association with PTC risk and clinical features.
Main Results:
- The frequency of the GC or CC genotype was significantly higher in PTC patients compared to controls (p=0.02, OR=1.7).
- Patients with the GC or CC genotype showed a significantly higher risk of aggressive clinical manifestations, including lymphatic involvement (p=0.0006, OR=3.7).
- The presence of the C allele was significantly associated with more profound PTC manifestations, such as lymph node involvement, vascular invasion, and multifocality.
Conclusions:
- The survivin gene -31 (G/C) polymorphism (rs 9904341) is associated with an increased risk of papillary thyroid carcinoma in the studied Iranian population.
- This genetic variation may serve as a potential biomarker for predicting PTC aggressiveness and clinical outcomes.
- Further research is warranted to elucidate the functional mechanisms linking this polymorphism to thyroid cancer development and progression.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation